Tandem Diabetes Care (TNDM) Reports Q2 Earnings: What Key Metrics Have to Say The headline numbers for Tandem Diabetes Care (TNDM) give insight into how the company performed in the quarter ended June…
Bears are Losing Control Over Tandem Diabetes Care (TNDM), Heres Why Its a Buy Now Tandem Diabetes Care (TNDM) appears to have found support after losing some value lately, as indicated by the formation of…
Tandem Diabetes Care, Inc. (TNDM) Expected to Beat Earnings Estimates: Should You Buy? Tandem Diabetes Care (TNDM) possesses the right combination of the two key ingredients for a likely earnings beat in its…
Tandem Diabetes Care (TNDM) Up 6.5% Since Last Earnings Report: Can It Continue? Tandem Diabetes Care (TNDM) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…
Tandem Diabetes Care (TNDM) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates Although the revenue and EPS for Tandem Diabetes Care (TNDM) give a sense of how its business performed in the…
Tandem Diabetes Care, Inc. (TNDM) Reports Q1 Loss, Tops Revenue Estimates Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -11.67% and 6.44%, respectively, for the quarter ended March 2025.…
2 Beaten-Down Stocks to Avoid in the Tariff-Fueled Correction With equity markets reeling due to President Donald Trumps tariffs, many investors are taking this opportunity to buy shares of…
Tandem Diabetes Care (TNDM) Down 8.9% Since Last Earnings Report: Can It Rebound? Tandem Diabetes Care (TNDM) reported earnings 30 days ago. Whats next for the stock? We take a look at earnings…
Heres What Key Metrics Tell Us About Tandem Diabetes Care (TNDM) Q4 Earnings While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in…
Tandem Diabetes Care, Inc. (TNDM) Reports Q4 Loss, Lags Revenue Estimates Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -76% and 1.07%, respectively, for the quarter ended December 2024.…
t:slim X2s Compatibility With Lillys Lyumjev Might Aid TNDM Stock By integrating ultra-rapid acting insulin such as Lyumjev, which responds faster than traditional insulin, Tandem Diabetes Care is enhancing the…
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, Aug. 09, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Citi raises Tandem Diabetes Care stock target by $17 By Investing.com Citi raises Tandem Diabetes Care stock target by $17…
Earnings call: Tandem Diabetes Care reports growth, new product success By Investing.com Earnings call: Tandem Diabetes Care reports growth, new product success…
TANDEM ALERT: Bragar Eagel & Squire, P.C. is Investigating Tandem Diabetes Care, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm NEW YORK, April 23, 2024 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights…
Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains? Tandem Diabetes Care, Inc. (TNDM) was a big mover last session on higher-than-average trading volume. The latest trend in earnings…